Establishment of spontaneously immortalized rat type 1 astroglial cell lines: The role of p53 in astroglial carcinogenesis

GLIA

Volumn 18, Issue 3, 1996, Pages 185-199

  Hiraga, Shoju ^a   Arita, Norio ^a   Ohnishi, Takanori ^a   Izumoto, Shuichi ^a   Taki, Takuyu ^a   Higuchi, Masahide ^a   Iwaisako, Kousuke ^a   Sakoda, Saburo ^a   Yamamoto, Youichi ^a   Hayakawa, Toru ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Transformation; Tumor suppressor gene

Indexed keywords

DNA; PROTEIN P53; RNA;

ANIMAL; ARTICLE; ASTROCYTE; ASTROCYTOMA; BIOSYNTHESIS; BRAIN TUMOR; CELL CLONE; CELL CULTURE; CELL DIVISION; CYTOLOGY; FLOW CYTOMETRY; GENETICS; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; MOUSE; NUDE MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; RAT; SOUTHERN BLOTTING;

ANIMALS; ASTROCYTES; ASTROCYTOMA; BLOTTING, SOUTHERN; BRAIN NEOPLASMS; CELL DIVISION; CLONE CELLS; CYTOLOGICAL TECHNIQUES; DNA, NEOPLASM; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; POLYMERASE CHAIN REACTION; RATS; RNA, NEOPLASM; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 12644261418     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(199611)18:3<185::AID-GLIA3>3.0.CO;2-Z     Document Type: Article

References (81)

1. Aaronson, S.A. and Todaro, G.J. (1968) Basis for acquisition of malignant potential by mouse cells cultivated in vitro. Science, 162:1024-1026.
2. Ahuja, H., Bar-Eli, M., Advani, S.H., Benchimol, S., and Cline, M.J. (1989) Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc. Natl. Acad. Sci. USA, 86:6783-6787.
3. Auersperg, N., Maines-Bandiera, S.L., Dyck, H.G., and Kruk, P.A. (1994) Characterization of cultured human ovarian surface epithelial cells: Phenotypic plasticity and premalignant changes. Lab. Invest., 71:510-518.
4. Bai, Y., Muragaki, Y., Obata, K., Iwata, K., and Ooshima, A. (1986) Immunological properties of monoclonal antibodies to human and rat prolyl 4-hydroxylase. J. Biochem., 99:1563-1570.
5. Baker, S.J., Fearon, E.R., Nigro, J.M., Hamilton, S.R., Preisinger, A.C., Jessup, J.M., van Tuinen, P., Ledbetter, D.H., Baker, D.F., Nakamura, Y., White, R., and Vogelstein, B. (1989) Chromosome 17 deletions and p53 gene mutations in colorectal carcinoma. Science, 244:217-221.
6. Baker, S.J., Preisinger, A.C., Jessup, J.M., Paraskeva, C., Markowitz, S., Wilson, J.K.V., Hamilton, S., and Vogelstein, B. (1990) p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50:7717-7722.
7. Barclay, N.A. and Hyden, H. (1978) Localization of the Thy-1 antigen in rat brain and spinal cord by immunofluorescence. J. Neurochem., 31:1375-1391.
8. Barrett, J.C. (1993) Cell senescence and apoptosis. In: Molecular Genetics of Nervous System Tumors. A.J. Levine and H.H. Schmideck, eds. Wiley-Liss, New York, pp. 61-72.
9. Barrett, J.C. and Ts'o, P.O. (1978) Evidence for the progressive nature of neoplastic transformation in vitro. Proc. Natl. Acad. Sci. USA, 75:3761-3765.
10. Bienz, B., Zakut-Houri, R., Givol, D., and Oren, M. (1984) Analysis of the gene coding for the murine cellular tumour antigen p53. EMBO J., 3:2179-2183.
11. Bischoff, F.Z., Yim, S.O., Pathak, S., Grant, G., Siciliano, M.J., Giovanella, B.C., Strong, L.C., and Tainsky, M.A. (1990) Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: Aneuploidy and immortalization. Cancer Res., 50:7979-7984.
12. Bogler, O., Su Huang, H.-H., and Cavenee, W.K. (1995) Loss of wild type p53 bestows a growth advantage on primary cortical astrocytes and facilitates their in vitro transformation. Cancer Res., 55:2746-2751.
13. Cameron, R.S. and Rakic, P. (1991) Glial cell lineage in the cerebral cortex: A review and synthesis. Glia, 4:124-137.
14. Campbell, D.G., Gagnon, J., Reid, K.B.M., and Williams, A.F. (1981) Rat brain Thy-1 gycoprotein. Biochem. J., 195:15-30.
15. Caron de Fromentel, C. and Soussi, T. (1992) TP 53 tumor suppressor genes: A model for investigating human mutagenesis. Genes Chromosomes Cancer, 4:1-15.
16. Dipaolo, J.A., Takano, K., and Popescu, N.C. (1972) Quantitation of chemically induced neoplastic transformation of BALB/3T3 cloned cell lines. Cancer Res., 32:2686-2695.
17. Eisenbarth, G.S., Walsh, F.S., and Nirenberg, M. (1987) Monoclonal antibody to a plasma membrane antigen of neurons. Proc. Natl. Acad. Sci. USA., 76:4913-4917.
18. Farber, E. (1984) Cellular biochemistry of the stepwise development of cancer with chemicals: G.H.H. Clowes Memorial Lecture. Cancer Res., 44:5463-5474.
19. Frederiksen, K., Jat, P.S., Valtz, N., Levy, D., and Mckay, R. (1988) Immortalization of precursor cells from the mammalian CNS. Neuron, 1:439-448.
20. Fults, D., Brockmeyer, D., Tullous, M.W., Pedone, C.A., and Cawthon, R.M. (1992) p53 mutation and loss of heterozygosity on chromosome 17 and 10 during human astrocytoma progression. Cancer Res., 52:674-679.
21. Gannon, J.V., Greaves, R., Iggo, R., and Lane, D.P. (1990) Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J., 9:1595-1602.
22. Hahn, M., Lorez, H., and Fischer, G. (1994) The immortalized asroglial cell line RC7 is a new model system for the study of nerve growth factor (NGF) regulation: Stimulation by interleukin-1β and transforming groth factor-β1 is additive and affected differently by dibutyric cyclic AMP. Glia, 10:286-295.
23. Halbert, C.L., Demers, G.W., and Galloway, D.A. (1991) The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol., 65:473-478.
24. Harlow, E., Crawford, L.V., Pim, D.C., and Williamson, N.M. (1981) Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol., 39:861-869,
25. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K., and Elledge, S.J. (1993) The p21 Cdk-ineracting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75:805-816.
26. Harvey, D.M. and Levine, A. (1991) p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev., 5:2375-2385.
27. Harvey, M., Sands, A.T., Weiss, R.S., Hegi, M., Wiseman, R.W., Pantazis, P., Giovanella, B.C., Tainsky, M.A., and Bradley, A. (1993) In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogens, 8:2457-2467.
28. Hayflick, L. (1965) The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res., 37:614-636.
29. Hayflick, L. and Moorhead, P.S. (1976) The cell biology of human aging. N. Engl. J. Med., 295:1302-1308.
30. Hayflick, L. and Moorhead, P.S. (1961) The serial cultivation of human diploid cells. Exp. Cell Res., 25:585-621.
31. Hinds, P., Finlay, C.A., Frewy, A.B., and Levine, A.J. (1987) Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines. Mol. Cell. Biol., 7:2863-2869.
32. Hiraga, S., Arita, N., Ohnishi, T., Taki, T., Izumoto, S., Yamamoto, H., Higuchi, M., and Hayakawa, T. (1995) Transformation of type 1 astrocytes with n-ethyl-n-nitrosourea: Establishment of an in vitro system and the role of the p53 gene. Glia, 13:51-63.
33. Hoyhtya, M., Myllyla, R., Pivca, J., Kivirikko, K.I., and Tryggvason, K. (1984) Monoclonal antibodies to human prolyl 4-hydroxylase. Eur. J. Biochem. 141:477-482.
34. James, C.D., Carlbom, E., Dumanski, J.P., Hansen, M., Nordenskjord, M., Collins, V.P., and Cavanee, W.B. (1988) Clonal genomic alterations in glioma malignancy stages. Cancer Res., 48:5546-5551.
35. Jat, P.S. and Sharp, P.A. (1989) Cell lines established by a temperature-sensitive simian virus 40 large T-antigen gene are growth restricted at the nonpermissive temperature. Mol. Cell. Biol., 9:1672-1681.
36. Jenkins, J.R., Rudge, K., and Currie, G.A. (1984) Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53. Nature, 312:651-654.
37. Jonczyk, P., White, A., Lum, K., Barrett, J.C., and Tlsty, T.D. (1993) Amplification potential in preneoplautic and neoplastic Syrian hamster embryo fibroblasts transformed by various carcinogens. Cancer Res., 53:3098-3102.
38. Kastan, M.B., Zhan, Q., El-Deiry, W.S., Carrier, F., Jack, T., Walsh, W.V., Plunkett, B.S., Vogelstein, B., and Fornace Jr. A.J. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GAD45 is defective in ataxia-telangiectasia. Cell, 71:587-597.
39. Kaul, S.C., Wadhwa, R., Sugihara, T., Obuchi, K., Komatsu, Y., and Mitui, Y. (1994) Identification of genetic events involved in early steps of immortalization of mouse fibroblasts. Biochem. Biophys. Acta., 1201:389-396.
40. Kelman, Z., Prokocimer, M., Peller, S., Kahn, Y., Rechavi, G., Manor, Y., Cohen, A., and Rotter, V. (1989) Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogeneous leukemia. Blood, 74:2318-2324.
41. Klein, C.B., Conway, K., Wang, X.W., Bhamra, R.K., Lin, X., Cohen, M.D., Annab, L., Barrett, J.C., and Costa, M. (1991) Senescence of nickel-transformed cells by an X chromosome: Possible epigenetic control. Science, 251:796-799.
42. Kokunai, T., Korosue, K., Tamaki, N., and Matsumoto, S. (1986) Promoting effect of 12-O-tetradecanoylphorbol-13-acetate on the in vitro malignant transformation of fetal rat brain cells exposed in utero to ethylnitrosourea. Cancer Res., 46:1377-1381.
43. Kuerbitz, S.J., Plunkett, B.S., Walsh, W.V., and Kastan, M.B. (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA, 89:7491-7495.
44. Kurahashi, H., Akagi, K., Karakawa, K., Nakamura, T., Dumanski, J.P., Sano, T., Okada, S., Takai, S., and Nishisho, T. (1994) Isolation and mapping of cosmid markers on human chromosome 22, including one within the the submicroscopically deleted region of DiGeorge syndrome. Hum. Genet., 93:248-254.
45. Laerum, O.D. and Rajewsky, M.F. (1975) Neoplastic transformation of fetal brain cells in culture after exposure to ethylnitrosourea in vivo. J. Natl. Cancer Inst., 55:1177-1184.
46. Lamb, P. and Crawford, L. (1986) Characterization of the human p53. Mol. Cell. Biol., 6:1379-1385.
47. Lantos, P.L. and Pilkington, G.J. (1979) The development of experimental brain tumors. A sequential light and electron microscope study of the subependymal plate. I. Early lesions (abnormal cell clusters). Acta. Neuropathol. (Berl.), 45:167-175, 1979.
48. Lieberman, T.A., Nusbaum, H.R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M.D., Ullrich, A., and Schlessinger, J. (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin. Nature, 313:144-147.
49. Livingstone, L.R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tlsty, T.D. (1992) Altered cell cycle arrest and gene amplification. Potential to accompany loss of wild-type p53. Cell, 70:923-935.
50. McCarthy, K.D. and de Vellis, J. (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissues. Cell. Biol., 85:890-920.
51. Mørk, S.J. (1984) Characterization of premalignant neurogenic rat cells in vitro. Anticancer Res., 4:189-195.
52. Newbold, R.F. and Overell, R.W. (1983) Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene. Nature, 304:648-651.
53. Nigro, J.M., Baker, S.J., Preisinger, A.C., Jessup, J.M., Hostetter, R., Clearly, K., Bigner, S.H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F.S., Weston, A., Modali, R., Harris, C.C., and Vogelstein, B. (1989) Mutations in the p53 in diverse human tumor types. Nature, 342:705-708.
54. Ning, Y., Weber, J.L., Killary, A.M., Ledbetter, D.H., Smith, J.R., and Pereira-Smith, O.M. (1991) Genetic analysis of indefinite division in human cells: Evidence for a cell senescence-related gene(s) on human chromosome 4. Proc. Natl. Acad. Sci. USA, 88:5635-5639.
55. Ohnishi, T., Arita, N., Hayakawa, T., Kato, K., and Kakinuma, A. (1993) Purification of motility factor (GMF) from human malignant glioma cells and its biological significance in tumor invasion. Biochem. Biophys. Res. Commun., 193:518-525.
56. Raff, M.C., Abney, E.R., Cohen, J., Lindsay, R., and Noble, M. (1983) Two types of astrocytes in cultures of developing rat white matter: Differences in morphology, surface gangliosides, and growth characteristics. J. Neurosci., 3:1289-1300.
57. Ranscht, B., Clapshaw, P.A., Price, J., and Seifert, W. (1982) Development of oligodendrocytes and Schwann cells studied with monoclonal antibody against galactocerebroside. Proc. Natl. Acad. Sci. USA, 79:2709-2713.
58. Rasheed, B.K.A., Fuller, G.N., Friedman, A.H., Bigner, D.D., and Bigner, S.H. (1991) Loss of heterozygosity for 10q loci in human gliomas. Genes Chromosomes Cancer, 5:75-82.
59. Rasheed, B.K.A., McLendon, R.E., Henry, J.E., Friedman, H.S., Freidman, A.H., Bigner, D.D., and Bigner, S.H. (1994) Alterations of TP53 gene in human gliomas. Cancer Res., 54:1324-1330.
60. Reifenberger, G., Liu L., Ichimura, K., Schmidt, E.E., and Collins, V.P. (1993) Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res., 53:2736-2739.
61. Rittling, S.R. and Denhardt, D.T. (1992) p53 mutations in spontaneously immortalized 3T12 but not 3T3 mouse embryo cells. Oncogene, 7:935-942.
62. Rovinski, B. and Benchimol, S. (1988) Immortalization of rat embryo fibroblasts by the cellular p53 oncogene. Oncogene, 2:445-452.
63. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989) Molecular Cloning. A Laboratory Manual. C. Noran, ed. Cold Spring Harbor Press, New York.
64. Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, A.J., and Howley, P.M. (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63:1129-1136.
65. Schiffer, D., Giordana, M.T., Lechner, C., and Paoletti, P. (1978) Cerebral tumors induced by transplacental ENU: Study of the different tumoral stages, particularly of early proliferations. Acta. Neuropathol. (Berl.), 41:27-31.
66. Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M., Cavanee, W., and Vogelstein, V. (1992) Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature, 355:846-847.
67. Smith, M.L., Chen, I.-T, Zhan, Q., Bae, I., Chen, C.-Y., Gilmer, T.M., Kastan, M.B., O'Conner, P.M., and Fornace Jr, A.J. (1994) Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science, 266:1376-1380.
68. Soussi, T., Caron de Fromentel, C., Breugnot, C., and May, E. (1988) Nucleotide sequence of cDNA encoding the rat p53 nuclear oncoprotein. Nucleic Acids Res., 16:11384.
69. Soussi, T., Caron de Fromentel, C., and May, P. (1992) Structural aspects of the p53 protein in relation to gene evolution. Oncogene, 5:945-952.
70. Stickland, J.E., Tomlinson, I.P., Pamshaw, A.L., Bromley, L., Potter, G.G., and McGee, J.O. (1993) Quantification of oncogene dosage in tumors by simultaneous dual-label hybridization. Oncogene, 8: 223-227.
71. Sugawara, O., Oshimura, M., Koi, M., Annab, L.A., and Barrett, J.C. (1990) Induction of cellular senescence in immortalized cells by human chromosome 1. Science, 247:707-710.
72. Todaro, G.J. and Green, H. (1963) Quantitative studies of the growth and their development into established lines. J. Cell Biol., 17:299-313.
73. Tokumitsu, M., Kadohama, T., and Ogawa, K. (1994) Infrequent loss of heterozygosity and mutation of the p53 gene in immortal and transformed mouse embryo fibroblasts. Mol. Carcinog., 10:52-57.
74. Tsukada, T., Tomooka, Y., Takai, S., Ueda, Y., Nishikawa, S., Yagi, T., Tokunaga, T., Takeda, N., Suda, Y., Abe, S., Matsuo, I., Ikawa, Y., and Arizawa, S. (1993) Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene, 8:3313-3322.
75. Vogelstein, B. and Kinzler, K.W. (1992) p53 function and dysfunction. Cell, 70:523-526.
76. von Deimling, A., Eibl, R.H., Ohgaki, H., Louis, D.N., von Ammon, K., Petersen, I., Kleihues, P., Chung, R.Y., Wiestler, O.D., and Seizinger, R. (1992) p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res., 52:2987-2990.
77. Werness, B.A., Levine, A.J., and Howley, P.M. (1990) Association of human papilloma virus type 16 and 18 E6 proteins with p53. Science, 248:76-79.
78. Whittemore, S.R., Neary, J., Kleitman, N., Sanon, H.R., Benigno, A., Donahue, R.P., and Norenberg, M.D. (1994) Isolation and characterization of conditionally immortalized astrocyte cell lines derived from adult human spinal cord. Glia, 10:211-226.
79. Yahanda, A.M., Bruner, J.M., Donehower, L.A., and Morrison, R.S. (1995) Astrocytes from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas. Mol. Cell. Biol., 15:4249-4259.
80. Yin, Y., Tainsky, M.A., Bischoff, F.Z., Strong, L.C., and Wahl, G.M. (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70:937-948.
81. Yoshida, J., Cravito, H., and Ranshoff, J. (1980) In vitro transformation of fetal brain cells from CDF rats exposed in utero to N-ethyl-N-nitrosourea: Morphologic and immunologic sudies. J. Natl. Cancer Inst., 64:1231-1239.